{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T04:15:27Z","timestamp":1654316127035},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3960\/jslrt.55.89","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T22:02:57Z","timestamp":1445464977000},"page":"89-96","source":"Crossref","is-referenced-by-count":1,"title":["Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus"],"prefix":"10.3960","volume":"55","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hamanomachi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Center for Cellular and Molecular Medicine, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology, Aichi Medical UniversitySchool of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Arber A: Acute myeloid leukaemia with myelodysplasia-related changes. In: Serdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al<\/i>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.124-126, 2008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Roboz GJ: Current treatment of acute myeloid leukemia. Curr Opin Oncol 24:711-719, 2012","DOI":"10.1097\/CCO.0b013e328358f62d"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Estey EH: Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol 88:318-327, 2013","DOI":"10.1002\/ajh.23404"},{"key":"4","unstructured":"4 Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, <i>et al<\/i>.: Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354-365, 2010"},{"key":"5","unstructured":"5 Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, <i>et al<\/i>.: Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912-2919, 2005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, <i>et al<\/i>.: Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10:3586-3592, 2004","DOI":"10.1158\/1078-0432.CCR-03-0754"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yuji K, Miyakoshi S, Kato D, Miura Y, Myojo T, <i>et al<\/i>.: Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. Biol Blood Marrow Transplant 11:314-318, 2005","DOI":"10.1016\/j.bbmt.2005.01.012"},{"key":"8","unstructured":"8 Goggins TF, Rizzieri DA, Prosnitz R, Gasparetto C, Long G, <i>et al<\/i>.: One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3-5\/6 HLA matched related donors. Blood 102:476b-477b, 2003 (<i>abstract<\/i>)"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sumi M, Shimizu I, Sato K, Ueki T, Akahane D, <i>et al<\/i>.: Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation. Int J Hematol 92:744-750, 2010","DOI":"10.1007\/s12185-010-0714-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Shimizu I, Kobayashi H, Nasu K, Otsuki F, Ueki T, <i>et al<\/i>.: Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis. Bone Marrow Transplant 44:617-618, 2009","DOI":"10.1038\/bmt.2009.69"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yamashita T, Sugimori C, Ishiyama K, Yamazaki H, Okumura H, <i>et al<\/i>.: Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections. Int J Hematol 89:238-242, 2009","DOI":"10.1007\/s12185-008-0234-9"},{"key":"12","unstructured":"12 Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, <i>et al<\/i>.: Hematopoietic cell transplantation (HCT)-specific cormobidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912-2919, 2005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Koyama M, Hashimoto D, Nagafuji K, Eto T, Ohno Y, <i>et al<\/i>.: Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning. Bone Marrow Transplant 49:110-115, 2015","DOI":"10.1038\/bmt.2013.134"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, <i>et al<\/i>.: Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 16:1099-1106, 2010","DOI":"10.1016\/j.bbmt.2010.02.013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Offner F, Schoch G, Fisher LD, Torok-Storb B, Martin PJ: Mortality hazard functions as related to neutropenia at different times after marrow transplantation. Blood 88:4058-4062, 1996","DOI":"10.1182\/blood.V88.10.4058.bloodjournal88104058"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kishi Y, Kami M, Miyakoshi S, Kanda Y, Murashige N, <i>et al<\/i>.: Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 80:34-40, 2005","DOI":"10.1097\/01.TP.0000163289.20406.86"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Matsuno N, Yamamoto H, Watanabe N, Uchida N, Ota H, <i>et al<\/i>.: Rapid T-cell chimerism switch and memory T-cell expansion are associated with pre-engraftment immune reaction early after cord blood transplantation. Br J Haematol 160:255-258, 2013","DOI":"10.1111\/bjh.12097"},{"key":"18","unstructured":"18 Uchida N, Wake A, Nakano N, Ishiwata K, Takagi S, <i>et al<\/i>.: Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. Transplantation 92:366-371, 2011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, <i>et al<\/i>.: Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood 120:4058-4067, 2012","DOI":"10.1182\/blood-2012-02-408864"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Gyurkocza B, Cao TM, Storb RF, Lange T, Leisenring W, <i>et al<\/i>.: Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant 15:1314-1322, 2009","DOI":"10.1016\/j.bbmt.2009.06.011"},{"key":"21","unstructured":"21 Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, <i>et al<\/i>.: Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 41:279-285, 2008"},{"key":"22","unstructured":"22 Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, <i>et al<\/i>.: Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193:68-79, 2006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, <i>et al<\/i>.: High incidence of human herpes virus 6-associated encephalitis\/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant 16:1596-1602, 2010","DOI":"10.1016\/j.bbmt.2010.05.009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Reusser P, Einsele H, Lee J, Volin L, Rovira M, <i>et al<\/i>.: Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99:1159-1164, 2002","DOI":"10.1182\/blood.V99.4.1159"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ishiyama K, Katagiri T, Ohata K, Hosokawa K, Kondo Y, <i>et al<\/i>.: Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation. Transpl Infect Dis 14:33-39, 2012","DOI":"10.1111\/j.1399-3062.2011.00662.x"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/55\/2\/55_89\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T01:51:43Z","timestamp":1599702703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/55\/2\/55_89\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.55.89","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}